Current concepts in the diagnosis and treatment of type 1 and type 2 autoimmune pancreatitis

Recent Patents on Inflammation and Allergy Drug Discovery

Volumn 5, Issue 2, 2011, Pages 136-149

  Detlefsen, Sönke ^a   Löhr, J Matthias ^b   Drewes, Asbjørn M ^c   Frøkjær, Jens B ^c   Klöppel, Günter ^d  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b KAROLINSKA INSTITUTE   (Sweden)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Autoantibodies; Autoimmune pancreatitis; Clinical features; Diagnosis; Histopathology; Treatment; Type 1; Type 2

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOGLOBULIN G4; MERCAPTOPURINE; PREDNISOLONE; PREDNISONE; RITUXIMAB; STEROID;

ARTICLE; AUTOIMMUNE PANCREATITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFECT; ENTERITIS; HISTOPATHOLOGY; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNOGLOBULIN BLOOD LEVEL; LABORATORY DIAGNOSIS; NEEDLE BIOPSY; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS ISLET CELL HYPERPLASIA; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; STEROID THERAPY; TREATMENT DURATION; TREATMENT PLANNING;

AUTOIMMUNE DISEASES; HUMANS; PANCREATITIS, CHRONIC; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 79954467990     PISSN: 1872213X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221311795399228     Document Type: Article

References (129)

1. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995; 40: 1561-8.
2. Ball WP, Baggenstoss AH, Bargen JA. Pancreatic lesions associated with chronic ulcerative colitis. Arch Pathol (Chic) 1950; 50: 347-58.
3. Sarles H, Sarles JC, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas - an autonomous pancreatic disease? Am J Dig Dis 1961; 6: 688-98.
4. Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: A variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991; 22: 387-95.
5. Ectors N, Maillet B, Aerts R, Geboes K, Donner A, Borchard F, et al. Non-alcoholic duct destructive chronic pancreatitis. Gut 1997; 41: 263-8.
6. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344: 732-8.
7. Abraham SC, Wilentz RE, Yeo CJ, Sohn TA, Cameron JL, Boitnott JK, et al. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: Are they all 'chronic pancreatitis'? Am J Surg Pathol 2003; 27: 110-20.
8. Zamboni G, Capelli P, Scarpa A, Bogina G, Pesci A, Brunello E, et al. Nonneoplastic mimickers of pancreatic neoplasms. Arch Pathol Lab Med 2009; 133: 439-53.
9. Hardacre JM, Iacobuzio-Donahue CA, Sohn TA, Abraham SC, Yeo CJ, Lillemoe KD, et al. Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis. Ann Surg 2003; 237: 853-8.
10. Kajiwara M, Gotohda N, Konishi M, Nakagohri T, Takahashi S, Kojima M, et al. Incidence of the focal type of autoimmune pancreatitis in chronic pancreatitis suspected to be pancreatic carcinoma: Experience of a single tertiary cancer center. Scand J Gastroenterol 2008; 43: 110-6.
11. Kennedy T, Preczewski L, Stocker SJ, Rao SM, Parsons WG, Wayne JD, et al. Incidence of benign inflammatory disease in patients undergoing Whipple procedure for clinically suspected carcinoma: A single-institution experience. Am J Surg 2006; 191: 437-41.
12. Sugumar A, Klöppel G, Chari ST. Autoimmune pancreatitis: Pathologic subtypes and their implications for its diagnosis. Am J Gastroenterol 2009; 104: 2308-10.
13. Detlefsen S, Drewes AM, Vyberg M, Klöppel G. Diagnosis of autoimmune pancreatitis by core needle biopsy: Application of six microscopic criteria. Virchows Arch 2009; 454: 531-9.
14. Zamboni G, Lüttges J, Capelli P, Frulloni L, Cavallini G, Pederzoli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: A study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004; 445: 552-63.
15. Park DH, Kim MH, Chari ST. Recent advances in autoimmune pancreatitis. Gut 2009; 58: 1680-9.
16. Sah RP, Chari ST, Pannala R, Sugumar A, Clain JE, Levy MJ, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology 2010; 139: 140-8.
17. Notohara K, Burgart LJ, Yadav D, Chari S, Smyrk TC. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: Clinicopathologic features of 35 cases. Am J Surg Pathol 2003; 27: 1119-27.
18. Chari ST, Klöppel G, Zhang L, Notohara K, Lerch MM, Shimosegawa T. Histopathologic and clinical subtypes of autoimmune pancreatitis: The Honolulu consensus document. Pancreas 2010; 39: 549-54.
19. Weber SM, Cubukcu-Dimopulo O, Palesty JA, Suriawinata A, Klimstra D, Brennan MF, et al. Lymphoplasmacytic sclerosing pancreatitis: Inflammatory mimic of pancreatic carcinoma. J Gastrointest Surg 2003; 7: 129-37.
20. Deshpande V, Chicano S, Finkelberg D, Selig MK, Mino-Kenudson M, Brugge WR, et al. Autoimmune pancreatitis: A systemic immune complex mediated disease. Am J Surg Pathol 2006; 30: 1537-45.
21. Detlefsen S, Sipos B, Zhao J, Drewes AM, Klöppel G. Autoimmune pancreatitis: Expression and cellular source of profibrotic cytokines and their receptors. Am J Surg Pathol 2008; 32: 986-95.
22. Klöppel G, Detlefsen S, Chari ST, Longnecker DS, Zamboni G. Autoimmune pancreatitis: The clinicopathological characteristics of the subtype with granulocytic epithelial lesions. J Gastroenterol 2010; 45: 787-93.
23. Chari ST, Longnecker DS, Klöppel G. The diagnosis of autoimmune pancreatitis: A Western perspective. Pancreas 2009; 38: 846-48.
24. Sah RP, Pannala R, Zhang L, Graham RP, Sugumar A, Chari ST. Eosinophilia and Allergic Disorders in Autoimmune Pancreatitis. Am J Gastroenterol 2010; 105(11): 2485-91.
25. Uchida K, Yazumi S, Nishio A, Kusuda T, Koyabu M, Fukata M, et al. Long-term outcome of autoimmune pancreatitis. J Gastroenterol 2009; 44: 726-32.
26. Gardner TB, Chari ST. Autoimmune pancreatitis. Gastroenterol Clin North Am 2008; 37: 439-60.
27. Kamisawa T, Okamoto A. Autoimmune pancreatitis: Proposal of IgG4-related sclerosing disease. J Gastroenterol 2006; 41: 613-25.
28. Kamisawa T, Anjiki H, Egawa N. Rapid changes in sclerosing cholangitis associated with autoimmune pancreatitis. Pancreas 2009; 38: 601-2.
29. Webster GJ, Pereira SP, Chapman RW. Autoimmune pancreatitis/IgG4-associated cholangitis and primary sclerosing cholangitis--overlapping or separate diseases? J Hepatol 2009; 51: 398-402.
30. Björnsson E, Chari S, Silveira M, Gossard A, Takahashi N, Smyrk T, et al. Primary sclerosing cholangitis associated with elevated immunoglobulin G4: Clinical characteristics and response to therapy. Am J Ther 2010; [Epub ahead of print].
31. Mendes FD, Jorgensen R, Keach J, Katzmann JA, Smyrk T, Donlinger J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 2006; 101: 2070-5.
32. Cheuk W, Chan AC, Lam WL, Chow SM, Crowley P, Lloydd R, et al. IgG4-related sclerosing mastitis: Description of a new member of the IgG4-related sclerosing diseases. Am J Surg Pathol 2009; 33: 1058-64.
33. Kasashima S, Zen Y, Kawashima A, Endo M, Matsumoto Y, Kasashima F. A new clinicopathological entity of IgG4-related inflammatory abdominal aortic aneurysm. J Vasc Surg 2009; 49: 1264-71.
34. Sakata N, Tashiro T, Uesugi N, Kawara T, Furuya K, Hirata Y, et al. IgG4-positive plasma cells in inflammatory abdominal aortic aneurysm: The possibility of an aortic manifestation of IgG4- related sclerosing disease. Am J Surg Pathol 2008; 32: 553-9.
35. Uehara T, Hamano H, Kawakami M, Koyama M, Kawa S, Sano K, et al. Autoimmune pancreatitis-associated prostatitis: Distinct clinicopathological entity. Pathol Int 2008; 58: 118-25.
36. Fukui T, Mitsuyama T, Takaoka M, Uchida K, Matsushita M, Okazaki K. Pancreatic cancer associated with autoimmune pancreatitis in remission. Intern Med 2008; 47: 151-5.
37. Ghazale A, Chari S. Is autoimmune pancreatitis a risk factor for pancreatic cancer? Pancreas 2007; 35: 376.
38. Inoue H, Miyatani H, Sawada Y, Yoshida Y. A case of pancreas cancer with autoimmune pancreatitis. Pancreas 2006; 33: 208-9.
39. Witkiewicz AK, Kennedy EP, Kennyon L, Yeo CJ, Hruban RH. Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: Case report and review of the literature. Hum Pathol 2008; 39: 1548-51.
40. Kamisawa T, Notohara K, Shimosegawa T. Two clinicopathologic subtypes of autoimmune pancreatitis: LPSP and IDCP. Gastroenterology 2010; 139: 22-5.
41. Pearson RK, Longnecker DS, Chari ST, Smyrk TC, Okazaki K, Frulloni L, et al. Controversies in clinical pancreatology: Autoimmune pancreatitis: Does it exist? Pancreas 2003; 27: 1-13.
42. Choi EK, Kim MH, Lee TY, Kwon S, Oh HC, Hwang CY, et al. The sensitivity and specificity of serum immunoglobulin G and immunoglobulin G4 levels in the diagnosis of autoimmune chronic pancreatitis: Korean experience. Pancreas 2007; 35: 156-61.
43. Kawa S, Hamano H. Assessment of serological markers for the diagnosis of autoimmune pancreatitis. J Jpn Pancreas Soc 2003; 17: 607-10.
44. Aparisi L, Farre A, Gomez-Cambronero L, Martinez J, De Las HG, Corts J, et al. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: Relevance for diagnosis of autoimmune pancreatitis. Gut 2005; 54: 703-9.
45. Nahon UK, Levy P, O'Toole D, Belmatoug N, Vullierme MP, Couvelard A, et al. Is idiopathic chronic pancreatitis an autoimmune disease? Clin Gastroenterol Hepatol 2005; 3: 903-9.
46. Kleeff J, Welsch T, Esposito I, Löhr M, Singer R, Büchler MW, et al. Autoimmune pancreatitis-a surgical disease? Chirurg 2006; 77: 154-65.
47. Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Morphological changes after steroid therapy in autoimmune pancreatitis. Scand J Gastroenterol 2004; 39: 1154-8.
48. Morselli-Labate AM, Pezzilli R. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: A systematic literature review and meta-analysis. J Gastroenterol Hepatol 2009; 24: 15-36.
49. Nishino T, Toki F, Oyama H, Shimizu K, Shiratori K. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med 2006; 45: 497-501.
50. Umemura T, Zen Y, Hamano H, Kawa S, Nakanuma Y, Kiyosawa K. Immunoglobin G4-hepatopathy: Association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 2007; 46: 463-71.
51. Okazaki K, Uchida K, Ohana M, Nakase H, Uose S, Inai M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 2000; 118: 573-81.
52. Frulloni L, Lunardi C, Simone R, Dolcino M, Scattolini C, Falconi M, et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 2009; 361: 2135-42.
53. Löhr JM, Faissner R, Koczan D, Bewerunge P, Bassi C, Brors B, et al. Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: Gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory process. Am J Gastroenterol 2010; 105: 2060-71.
54. Endo T, Takizawa S, Tanaka S, Takahashi M, Fujii H, Kamisawa T, et al. Amylase alpha-2A autoantibodies: Novel marker of autoimmune pancreatitis and fulminant type 1 diabetes. Diabetes 2009; 58: 732-7.
55. Farrell JJ, Garber J, Sahani D, Brugge WR. EUS findings in patients with autoimmune pancreatitis. Gastrointest Endosc 2004; 60: 927-36.
56. Irie H, Honda H, Baba S, Kuroiwa T, Yoshimitsu K, Tajima T, et al. Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol 1998; 170: 1323-7.
57. Procacci C, Carbognin G, Biasiutti C, Frulloni L, Bicego E, Spoto E, et al. Autoimmune pancreatitis: Possibilities of CT characterization. Pancreatology 2001; 1: 246-53.
58. Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Autoimmune pancreatitis. N Engl J Med 2006; 355: 2670-6.
59. Taniguchi T, Kobayashi H, Nishikawa K, Iida E, Michigami Y, Morimoto E, et al. Diffusion-weighted magnetic resonance imaging in autoimmune pancreatitis. Jpn J Radiol 2009; 27: 138-42.
60. Fukumori K, Shakado S, Miyahara T, Fukuizumi K, Takemoto R, Nishi H, et al. Atypical manifestations of pancreatitis with autoimmune phenomenon in an adolescent female. Intern Med 2005; 44: 886-91.
61. Otsuki M, Chung JB, Okazaki K, Kim MH, Kamisawa T, Kawa S, et al. Asian diagnostic criteria for autoimmune pancreatitis: Consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol 2008; 43: 403-8.
62. Takayama M, Hamano H, Ochi Y, Saegusa H, Komatsu K, Muraki T, et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol 2004; 99: 932-7.
63. Shanbhogue AK, Fasih N, Surabhi VR, Doherty GP, Shanbhogue DK, Sethi SK. A clinical and radiologic review of uncommon types and causes of pancreatitis. Radiographics 2009; 29: 1003-26.
64. Kawakami H, Kuwatani M, Shinada K, Yamato H, Hirano S, Kondo S, et al. Autoimmune pancreatitis associated with hemorrhagic pseudocysts: A case report and literature review. Intern Med 2008; 47: 603-8.
65. Nishimura T, Masaoka T, Suzuki H, Aiura K, Nagata H, Ishii H. Autoimmune pancreatitis with pseudocysts. J Gastroenterol 2004; 39: 1005-10.
66. Welsch T, Kleeff J, Esposito I, Büchler MW, Friess H. Autoimmune pancreatitis associated with a large pancreatic pseudocyst. World J Gastroenterol 2006; 12: 5904-6.
67. Dietrich CF, Hirche TO, Ott M, Ignee A. Real-time tissue elastography in the diagnosis of autoimmune pancreatitis. Endoscopy 2009; 41: 718-20.
68. Lee TY, Kim MH, Park DH, Seo DW, Lee SK, Kim JS, et al. Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer. AJR Am J Roentgenol 2009; 193: 343-8.
69. Nakamoto Y, Saga T, Ishimori T, Higashi T, Mamede M, Okazaki K, et al. FDG-PET of autoimmune-related pancreatitis: Preliminary results. Eur J Nucl Med 2000; 27: 1835-8.
70. Klöppel G. Chronic pancreatitis, pseudotumors and other tumorlike lesions. Mod Pathol 2007; 20 (Suppl 1): S113-S31.
71. Esposito I, Born D, Bergmann F, Longerich T, Welsch T, Giese NA, et al. Autoimmune pancreatocholangitis, non-autoimmune pancreatitis and primary sclerosing cholangitis: A comparative morphological and immunological analysis. PLoS ONE 2008; 3: e2539.
72. Sahani DV, Kalva SP, Farrell J, Maher MM, Saini S, Mueller PR, et al. Autoimmune pancreatitis: Imaging features. Radiology 2004; 233: 345-52.
73. Chari ST, Takahashi N, Levy MJ, Smyrk TC, Clain JE, Pearson RK, et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol 2009; 7: 1097-103.
74. Detlefsen S, Sipos B, Feyerabend B, Klöppel G. Fibrogenesis in alcoholic chronic pancreatitis: The role of tissue necrosis, macrophages, myofibroblasts and cytokines. Mod Pathol 2006; 19: 1019-26.
75. Detlefsen S, Sipos B, Feyerabend B, Klöppel G. Pancreatic fibrosis associated with age and ductal papillary hyperplasia. Virchows Arch 2005; 447: 800-5.
76. Klöppel G, Detlefsen S, Feyerabend B. Fibrosis of the pancreas: The initial tissue damage and the resulting pattern. Virchows Arch 2004; 445: 1-8.
77. Klöppel G, Lüttges J, Sipos B, Capelli P, Zamboni G. Autoimmune pancreatitis: Pathological findings. JOP 2005; 6: 97-101.
78. Klöppel G, Sipos B, Zamboni G, Kojima M, Morohoshi T. Autoimmune pancreatitis: Histo- and immunopathological features. J Gastroenterol 2007; 42 Suppl 18: 28-31.
79. Suda K, Takase M, Fukumura Y, Kashiwagi S. Pathology of autoimmune pancreatitis and tumor-forming pancreatitis. J Gastroenterol 2007; 42 (Suppl 18): 22-7.
80. Levy P, Hammel P, Ruszniewski P. Diagnostic challenge in autoimmune pancreatitis: Beware of shipwreck! Gut 2008; 57: 1646-7.
81. Levy MJ, Jondal ML, Clain J, Wiersema MJ. Preliminary experience with an EUS-guided trucut biopsy needle compared with EUS-guided FNA. Gastrointest Endosc 2003; 57: 101-6.
82. Wiersema MJ, Levy MJ, Harewood GC, Vazquez-Sequeiros E, Jondal ML, Wiersema LM. Initial experience with EUS-guided trucut needle biopsies of perigastric organs. Gastrointest Endosc 2002; 56: 275-8.
83. Bang SJ, Kim MH, Kim dH, Lee TY, Kwon S, Oh HC, et al. Is pancreatic core biopsy sufficient to diagnose autoimmune chronic pancreatitis? Pancreas 2008; 36: 84-9.
84. Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Zhang L, et al. Diagnosis of autoimmune pancreatitis: The Mayo Clinic experience. Clin Gastroenterol Hepatol 2006; 4: 1010-6.
85. Deshpande V, Mino-Kenudson M, Brugge W, Lauwers GY. Autoimmune pancreatitis: More than just a pancreatic disease? A contemporary review of its pathology. Arch Pathol Lab Med 2005; 129: 1148-54.
86. Hirano K, Fukushima N, Tada M, Isayama H, Mizuno S, Yamamoto K, et al. Diagnostic utility of biopsy specimens for autoimmune pancreatitis. J Gastroenterol 2009; 44: 765-73.
87. Levy MJ, Wiersema MJ, Chari ST. Chronic pancreatitis: Focal pancreatitis or cancer? Is there a role for FNA/biopsy? Autoimmune pancreatitis. Endoscopy 2006; 38 (Suppl 10): S30-S35
88. Mizuno N, Bhatia V, Hosoda W, Sawaki A, Hoki N, Hara K, et al. Histological diagnosis of autoimmune pancreatitis using EUSguided trucut biopsy: A comparison study with EUS-FNA. J Gastroenterol 2009; 44: 742-50.
89. Deshpande V, Mino-Kenudson M, Brugge WR, Pitman MB, Fernandez-del CC, Warshaw AL, et al. Endoscopic ultrasound guided fine needle aspiration biopsy of autoimmune pancreatitis: Diagnostic criteria and pitfalls. Am J Surg Pathol 2005; 29: 1464-71.
90. Kamisawa T, Tu Y, Nakajima H, Egawa N, Tsuruta K, Okamoto A. Usefulness of biopsying the major duodenal papilla to diagnose autoimmune pancreatitis: A prospective study using IgG4- immunostaining. World J Gastroenterol 2006; 12: 2031-3.
91. Moon SH, Kim MH, Park dH, Song TJ, Eum J, Lee SS, et al. IgG4 immunostaining of duodenal papillary biopsy specimens may be useful for supporting a diagnosis of autoimmune pancreatitis. Gastrointest Endosc 2010; 71: 960-6.
92. Sugumar A, Chari ST. Diagnosis and treatment of autoimmune pancreatitis. Curr Opin Gastroenterol 2010; 26: 513-8.
93. Japan Pancreas Society. Diagnostic criteria for autoimmune pancreatitis. J Jpn Pancreas Soc 2002; 17: 585-7.
94. Okazaki K, Kawa S, Kamisawa T, Naruse S, Tanaka S, Nishimori I, et al. Clinical diagnostic criteria of autoimmune pancreatitis: Revised proposal. J Gastroenterol 2006; 41: 626-31.
95. Okazaki K, Uchida K, Matsushita M, Takaoka M. How to diagnose autoimmune pancreatitis by the revised Japanese clinical criteria. J Gastroenterol 2007; 42 (Suppl 18): 32-8.
96. Okazaki K, Kawa S, Kamisawa T, Ito T, Inui K, Irie H, et al. Japanese clinical guidelines for autoimmune pancreatitis. Pancreas 2009; 38: 849-66.
97. Kim KP, Kim MH, Kim JC, Lee SS, Seo DW, Lee SK. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol 2006; 12: 2487-96.
98. Kamisawa T, Satake K. Therapeutic strategy for autoimmune pancreatitis. Adv Med Sci 2008; 1-4
99. Moon SH, Kim MH, Park DH, Hwang CY, Park SJ, Lee SS, et al. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut 2008; 57: 1704-12.
100. Ghazale A, Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007; 102: 1646-53.
101. Raina A, Krasinskas AM, Greer JB, Lamb J, Fink E, Moser AJ, et al. Serum immunoglobulin G fraction 4 levels in pancreatic cancer: Elevations not associated with autoimmune pancreatitis. Arch Pathol Lab Med 2008; 132: 48-53.
102. Kamisawa T, Shimosegawa T, Okazaki K, Nishino T, Watanabe H, Kanno A, et al. Standard steroid therapy for autoimmune pancreatitis. Gut 2009; 58(11): 1504-7.
103. Frulloni L, Scattolini C, Katsotourchi AM, Amodio A, Gabbrielli A, Zamboni G, et al. Exocrine and endocrine pancreatic function in 21 patients suffering from autoimmune pancreatitis before and after steroid treatment. Pancreatology 2010; 10: 129-33.
104. Kamisawa T, Yoshiike M, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Treating patients with autoimmune pancreatitis: Results from a long-term follow-up study. Pancreatology 2005; 5: 234-8.
105. Schneider A, Löhr JM, Singer MV. The M-ANNHEIM classification of chronic pancreatitis: Introduction of a unifying classification system based on a review of previous classifications of the disease. J Gastroenterol 2007; 42: 101-19.
106. Chari ST, Singer MV. The problem of classification and staging of chronic pancreatitis. Proposals based on current knowledge of its natural history. Scand J Gastroenterol 1994; 29: 949-60.
107. Park DH, Kim MH, Oh HB, Kwon OJ, Choi YJ, Lee SS, et al. Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis. Gastroenterology 2008; 134: 440-6.
108. Church NI, Pereira SP, Deheragoda MG, Sandanayake N, Amin Z, Lees WR, et al. Autoimmune pancreatitis: Clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol 2007; 102: 2417-25.
109. Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 2010; 62: 1755-62.
110. Cornell LD, Chicano SL, Deshpande V, Collins AB, Selig MK, Lauwers GY, et al. Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol 2007; 31: 1586-97.
111. Detlefsen S, Bräsen JH, Zamboni G, Capelli P, Klöppel G. Deposition of complement C3c, immunoglobulin (Ig)G4 and IgG at the basement membrane of pancreatic ducts and acini in autoimmune pancreatitis. Histopathology 2010; 57: 825-35.
112. Yamamoto M, Naishiro Y, Suzuki C, Kokai Y, Suzuki R, Honda S, et al. Proteomics analysis in 28 patients with systemic IgG4-related plasmacytic syndrome. Rheumatol Int 2010; 30: 565-8.
113. Saeki T, Ito T, Yamazaki H, Imai N, Nishi S. Hypocomplementemia of unknown etiology: An opportunity to find cases of IgG4-positive multi-organ lymphoproliferative syndrome. Rheumatol Int 2009; 30: 99-103.
114. Taniguchi T, Okazaki K, Okamoto M, Seko S, Tanaka J, Uchida K, et al. High prevalence of autoantibodies against carbonic anhydrase II and lactoferrin in type 1 diabetes: Concept of autoimmune exocrinopathy and endocrinopathy of the pancreas. Pancreas 2003; 27: 26-30.
115. Guarneri F, Guarneri C, Benvenga S. Helicobacter pylori and autoimmune pancreatitis: Role of carbonic anhydrase via molecular mimicry? J Cell Mol Med 2005; 9: 741-4.
116. Kawa S, Ota M, Yoshizawa K, Horiuchi A, Hamano H, Ochi Y, et al. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 2002; 122: 1264-9.
117. Ota M, Katsuyama Y, Hamano H, Umemura T, Kimura A, Yoshizawa K, et al. Two critical genes (HLA-DRB1 and ABCF1) in the HLA region are associated with the susceptibility to autoimmune pancreatitis. Immunogenetics 2007; 59: 45-52.
118. Jesnowski R, Isaksson B, Mohrcke C, Bertsch C, Bulajic M, Schneider-Brachert W, et al. Helicobacter pylori in autoimmune pancreatitis and pancreatic carcinoma. Pancreatology 2010; 10: 462-6.
119. Kobayashi, H., Endo, T., Sakuraoka, A. Detection method and detection reagent for autoimmune pancreatitis or fulminant type-1 diabetes. WO2008136510 (2008) & US20100129832 (2010).
120. Tedder, T., Hamaguchi, Y., Gron, H., Yazawa, N. Anti-CD19 antibody therapy for autoimmune disease. US20060263357 (2006) & US20100158901 (2010).
121. Aicher, B., Lomow, A. Use of GSK-3 inhibitors for preventing and treating pancreatic autoimmune disorders. US20080207594 (2008).
122. Cuzzocrea S, Malleo G, Genovese T, Mazzon E, Esposito E, Muia C, et al. Effects of glycogen synthase kinase-3beta inhibition on the development of cerulein-induced acute pancreatitis in mice. Crit Care Med 2007; 35: 2811-21.
123. Festen EA, Goyette P, Scott R, Annese V, Zhernakova A, Lian J, et al. Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis. Gut 2009; 58: 799-804.
124. Sivakumar, P., Jaspers, S. R. IL-21 antagonists. US2009075341 (2009).
125. Hjorth, S. A., Bodensgaard, K., and Madsen, D. IL-21 variants. US20100143292 (2010).
126. Lupia E, Goffi A, De GP, Azzolino O, Bosco O, Patrucco E, et al. Ablation of phosphoinositide 3-kinase-gamma reduces the severity of acute pancreatitis. Am J Pathol 2004; 165: 2003-11.
127. Dhanak, D., Knight, S. D. Thiazolones for use as PI3 kinase inhibitors. US2009082349 (2009).
128. Pasricha, P. J. and Chen, J. Gastrointestinal electrical stimulation for the treatment of pancreatitis. WO2009092027 (2009).
129. Knudson, M. B., Wilson, R. R., Tweden, K. S., Conrad, T. R. Nerve stimulation and blocking for treatment of gastrointestinal disorders. US20100168815 (2010).